For INVESTMENT PRODUCTS Sample Clauses

For INVESTMENT PRODUCTS the REWRITTEN BUSINESS WINDOW is 3 months prior to and 3 months after the issue date of a New Product or a deposit into an Existing contract. RULES FOR MONEY COMING INTO A NEW LIFE POLICY --------------------------------------------- PERMANENT TO PERMANENT / TERM TO TERM / PERMANENT TO TERM LIFE -------------------------------------------------------------- FULL FIRST-YEAR COMMISSIONS will be paid on the part of the New premium in the New Product that exceeds the premium level of the Old Product.
AutoNDA by SimpleDocs
For INVESTMENT PRODUCTS the REWRITTEN BUSINESS WINDOW is 3 months prior to and 3 months after the issue date of a New Product or a deposit into an Existing contract. Enterprise Selling Agreement MetLife Version - September 2003 RULES FOR MONEY COMING INTO A NEW LIFE POLICY PERMANENT TO PERMANENT / TERM TO TERM / PERMANENT TO TERM LIFE FULL FIRST-YEAR COMMISSIONS will be paid on the part of the New premium in the New Product that exceeds the premium level of the Old Product. - PARTIAL FIRST-YEAR COMMISSIONS will be paid on premium dollars in the New Product up to the premium level of the Old Product. The partial commission payable will be determined based on the age of the old policy being rewritten. This applies to "roll-overs" directly into the Cash Value and Paid-Up Riders. Please refer to the table below. ----------------------------------------------------------- PERCENT OF NORMAL FYC ----------------------------------------------------------- YEARS OLD POLICY HAS UP TO OLD PREMIUM ABOVE OLD PREMIUM BEEN IN-FORCE LEVEL (1) LEVEL ----------------------------------------------------------- Less Than 5 0% 100% ----------------------------------------------------------- 5 but less than 6 25% 100% ----------------------------------------------------------- 6 but less than 7 30% 100% ----------------------------------------------------------- 7 but less than 8 35% 100% ----------------------------------------------------------- 8 but less than 9 40% 100% ----------------------------------------------------------- 9 but less than 10 45% 100% ----------------------------------------------------------- 10 or more 50% 100% -----------------------------------------------------------
For INVESTMENT PRODUCTS the REWRITTEN BUSINESS WINDOW is 3 months prior to and 3 months after the issue date of a New Product or a deposit into an Existing contract. RULES FOR MONEY COMING INTO A NEW LIFE POLICY PERMANENT TO PERMANENT / TERM TO TERM / PERMANENT TO TERM LIFE FULL FIRST-YEAR COMMISSIONS will be paid on the part of the New premium in the New Product that exceeds the premium level of the Old Product. - PARTIAL FIRST-YEAR COMMISSIONS will be paid on premium dollars in the New Product up to the premium level of the Old Product. The partial commission payable will be determined based on the age of the old policy being rewritten. This applies to "roll-overs" directly into the Cash Value and Paid-Up Riders. Please refer to the table below. PERCENT OF NORMAL FYC --------------------- YEARS OLD POLICY HAS UP TO OLD PREMIUM ABOVE OLD PREMIUM BEEN IN-FORCE LEVEL (1) LEVEL ------------- --------- ----- Less Than 5 0% 100% 5 but less than 6 25% 100% 6 but less than 7 30% 100% 7 but less than 8 35% 100% 8 but less than 9 40% 100% 9 but less than 10 45% 100% 10 or more 50% 100%

Related to For INVESTMENT PRODUCTS

  • Acquisition for Investment The Purchaser is a “non-US person” as defined in Regulation S, acquiring the Shares solely for the its own account for the purpose of investment and not with a view to or for sale in connection with a distribution to anyone. 投资目的。购买人是符合规则S下定义的“非美国主体”,购买此合同下的股票仅出于其个人的投资目的,不是为了向其他人分销。

  • Purchase for Investment (a) Each Limited Partner hereby represents and warrants to the General Partner and to the Partnership that the acquisition of his Partnership Interest is made as a principal for his account for investment purposes only and not with a view to the resale or distribution of such Partnership Interest.

  • Combination Products If a LICENSED PRODUCT is sold to any third party in combination with other products, devices, components or materials that are capable of being sold separately and are not subject to royalties hereunder (“OTHER PRODUCTS,” with the combination of products being referred to as “COMBINATION PRODUCTS” and the Other Product and Licensed Product in such Combination Product being referred to as the “COMPONENTS”), the NET SALES of such LICENSED PRODUCT included in such COMBINATION PRODUCT shall be calculated by multiplying the NET SALES of the COMBINATION PRODUCT by the fraction A/(A+B), where A is the average NET SALES price of such LICENSED PRODUCT in the relevant country, as sold separately, and B is the total average NET SALES price of all OTHER PRODUCTS in the COMBINATION PRODUCT in the relevant country, as sold separately. If, in any country, any COMPONENT is not sold separately, NET SALES for royalty determination shall be determined by the formula [C / (C+D)], where C is the aggregate average fully absorbed cost of the Licensed Product components during the prior Royalty Period and D is the aggregate average fully absorbed cost of the other essential functional components during the prior Royalty Period, with such costs being determined in accordance with generally accepted accounting principles. To the extent that any SUBLICENSE INCOME relates to a COMBINATION PRODUCT or is otherwise calculated based on the value of one or more licenses or intellectual property rights held by the COMPANY, an AFFILIATE or SUBLICENSEE, COMPANY shall determine in good faith and report to THE PARTIES the share of such payments reasonably attributable to COMPANY’s or such AFFILIATE’s sublicense of the rights granted hereunder, based upon their relative importance and proprietary protection, which portion shall be the SUBLICENSE INCOME. THE PARTIES shall have the right to dispute such sharing determination in accordance with the dispute provisions of the AGREEMENT.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Other Products After clinical or other evidence, provided in writing [***] to Company, demonstrating the practicality of a particular market or use within the LICENSED FIELD which is not being developed or commercialized by Company, Company shall either provide JHU with a reasonable development plan and start development or attempt to reasonably sublicense the particular market or use to a third party. If within six (6) months of such notification [***] Company has not initiated such development efforts or sublicensed that particular market or use, JHU may terminate this license for such particular market or use. This Paragraph shall not be applicable if Company reasonably demonstrates to JHU that commercializing such LICENSED PRODUCT(S) or LICENSED SERVICE(S) or granting such a sublicense in said market or use would have a potentially adverse commercial effect upon marketing or sales of the LICENSED PRODUCT(S) developed and being sold by Company.

  • Purchase for Own Account for Investment Purchaser is purchasing the Shares for Purchaser’s own account for investment purposes only and not with a view to, or for sale in connection with, a distribution of the Shares within the meaning of the Securities Act. Purchaser has no present intention of selling or otherwise disposing of all or any portion of the Shares and no one other than Purchaser has any beneficial ownership of any of the Shares.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Acquisition of Shares for Investment Sellers are acquiring the shares comprising the Stock Consideration for investment and not with a view toward sale in connection with any distribution thereof in violation of the Securities Act. Parent hereby acknowledges and agrees that the shares comprising the Stock Consideration may not be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of without registration under the Securities Act, except pursuant to an exemption from such registration available under such Act, and without compliance with state and foreign securities Laws, in each case, to the extent applicable.

  • Products 1.1. The information (including but not limited to the quantity, rated hashrate, unit price (“Unit Price”), total price for one item (“Total Price (One Item)”), total price for all the items (“Total Purchase Price”) of Products to be purchased by Party B from Party A is as follows (“Products”):

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

Time is Money Join Law Insider Premium to draft better contracts faster.